Slow Capital, Inc. Bei Gene, Ltd. Transaction History
Slow Capital, Inc.
- $789 Million
- Q2 2025
A detailed history of Slow Capital, Inc. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Slow Capital, Inc. holds 18,083 shares of BGNE stock, worth $4.1 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
18,083
Previous 12,237
47.77%
Holding current value
$4.1 Million
Previous $2.77 Million
47.76%
% of portfolio
0.52%
Previous 0.38%
Shares
2 transactions
Others Institutions Holding BGNE
# of Institutions
282Shares Held
35.8MCall Options Held
110KPut Options Held
111K-
Baker Bros. Advisors LP New York, NY8.8MShares$1.99 Billion23.78% of portfolio
-
Primecap Management CO Pasadena, CA5.09MShares$1.15 Billion0.94% of portfolio
-
Capital International Investors Los Angeles, CA4.89MShares$1.11 Billion0.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.71MShares$615 Million0.09% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E91.03MShares$234 Million7.2% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.5B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...